Grove AI raised $4.9 million in a seed funding round led by A* to scale its team and redefine clinical trials with Agentic AI.

Jan 07, 2025•7 months ago

Amount Raised

$4.9 Million

Round Type

seed

San FranciscoMachine LearningArtificial IntelligenceBiotechnologyHealth Care

Investors

Upfront VenturesPear VcLife X VenturesAfore CapitalA*

Description

Grove AI announced a $4.9 million seed fundraise to enhance its clinical trial management platform. The investment will help the company create participant-centered ecosystems driven by real-time data.

Company Information

Company

Grove AI

Location

San Francisco, California, United States

About

Grove AI revolutionizes clinical trials with its AI-powered participant relationship management (PRM) platform, delivering actionable insights and accelerating critical trial processes. Grove empowers research organizations to streamline operations, engage participants, and accelerate life-saving therapies. With Grove, clinical trials shift from cumbersome, manual workflows to adaptive, data-driven ecosystems that operate at the speed of innovation—bringing life-saving treatments to patients faster than ever.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns